Research advances in new anti-HBV targets and related drugs / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
; (6): 379-384, 2016.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-498547
Responsible library:
WPRO
ABSTRACT
Interferon and nucleotide/nucleoside analogues are currently widely used in the management of chronic hepatitis B virus ( HBV) infections, but are facing problems such as poor sustained virologic response, low HBsAg clearance rate and a high risk of recurrence after drug withdraw.Exploring new target of anti-HBV agent has become a hot topic in recent years.This paper reviews the research progress on new anti-HBV targets and related drugs.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Clinical Infectious Diseases
Year:
2016
Document type:
Article